NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).
about
Molecular Aspects of Head and Neck Cancer TherapyEpigenetic Modifications and Accumulation of DNA Double-Strand Breaks in Oral Lichen Planus Lesions Presenting Poor Response to Therapy.Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus Venom.NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cellsAndrogen receptor activity modulates responses to cisplatin treatment in bladder cancerOvercoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axisCharacterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.Epigenetics and its role in periodontal diseases: a state-of-the-art review.Histone modifications: Targeting head and neck cancer stem cells.Anti-apoptotic NF-κB and "gain of function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF productionCisplatin activates volume-sensitive like chloride channels via purinergic receptor pathways in nasopharyngeal carcinoma cells.Tackling breast cancer chemoresistance with nano-formulated siRNA.Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to TherapyEnhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallateEpigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy.Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells.Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop.Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.Reduced chromatin acetylation of malignant salivary gland tumors correlates with enhanced proliferation.Leveraging Genomics for Head and Neck Cancer Treatment.Targeting the DNA Damage Response in OSCC with TP53 Mutations.
P2860
Q28082815-58197551-1935-4F89-8E1F-3A7B8BFD6922Q35724003-BA62997F-BB0F-4329-926B-EDCD90138F66Q35741628-495A2574-8FFF-478C-A565-65D359859356Q36638317-C31F15C8-81E1-4EEF-BB74-97D8151EE461Q37309839-BC986BF6-A407-49F3-AD70-AED8F1898B5FQ37520579-9354569B-37A8-4CAC-859D-208A8B4FAF95Q37580192-81703921-2763-47E7-80C1-BD75CD8D8AD3Q37687338-585FB6A9-42F3-4477-9A21-D1225A3CB355Q37693385-0CECB66A-D9D2-4D0C-B02A-8CDE375551EBQ38270260-34674893-275C-445A-8CF4-C49F2828826AQ38271597-42CA04E4-C81D-4BBB-AC15-6861BEEDABFAQ38941853-CC805FF6-2FDB-4377-BE0E-B0F4A4F9F44AQ38955222-0C5C146B-92AC-45FF-9936-842D78C1BD14Q38959517-365F5554-788D-4F1A-B58C-772B9C918E8AQ39433158-050E266D-E84C-400E-8684-190B4912F3CAQ40570273-51E2CC6F-D3D8-4E53-829C-FD2F7B5EFB3FQ41064275-7E281692-2E64-495B-9F89-E56FD8450F90Q42089892-AAB0C3B4-49D3-4C6D-8F5F-E33E9177C51CQ47137624-31EE9EDD-7AFB-4475-BDE3-8936D91AD951Q48120446-0A06E83F-5CBB-4FD8-B323-FEC003F45433Q48276258-32C54688-B755-4B00-8EEC-E68B761DE938Q50116331-BB9E9911-7568-40A8-848C-17A89FFCB12EQ52729908-6A86486D-10A5-43ED-8B55-A0C76106D586
P2860
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NFκB mediates cisplatin resist ...... uamous cell carcinoma (HNSCC).
@en
NFκB mediates cisplatin resist ...... d neck squamous cell carcinoma
@nl
type
label
NFκB mediates cisplatin resist ...... uamous cell carcinoma (HNSCC).
@en
NFκB mediates cisplatin resist ...... d neck squamous cell carcinoma
@nl
prefLabel
NFκB mediates cisplatin resist ...... uamous cell carcinoma (HNSCC).
@en
NFκB mediates cisplatin resist ...... d neck squamous cell carcinoma
@nl
P2093
P2860
P50
P1433
P1476
NFκB mediates cisplatin resist ...... uamous cell carcinoma (HNSCC).
@en
P2093
Chiara Zagni
Fernanda S Giudice
Luciana K Rosselli-Murai
Luciana O Almeida
Rogerio M Castilho
P2860
P304
P356
10.1016/J.FOB.2013.12.003
P577
2013-12-30T00:00:00Z